Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03129399
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
GDL | 2-ACETAMIDO-2-DEOXY-D-GLUCONO-1,5- LACTONE | A,B | 1UR9 | 0.78 | |
GDL | 2-ACETAMIDO-2-DEOXY-D-GLUCONO-1,5- LACTONE | A,B,C,D,E,F | 1O7A | 0.78 | |
GDL | 2-ACETAMIDO-2-DEOXY-D-GLUCONO-1,5- LACTONE | A,B | 1UR8 | 0.78 | |
M11 | N^6^-[(1R,2S)-1-({[(1R)-1-carboxy- 2-methylpropyl]oxy}carbonyl)-2- sulfanylpropyl]-6-oxo-L-lysine | A | 2VE1 | 0.71 | |
M11 | N^6^-[(1R,2S)-1-({[(1R)-1-carboxy- 2-methylpropyl]oxy}carbonyl)-2- sulfanylpropyl]-6-oxo-L-lysine | A | 2VCM | 0.71 | |
FSI | 5-(ACETYLAMINO)-2,6-ANHYDRO-3,5- DIDEOXY-3-FLUORONONONIC ACID | A | 2AH2 | 0.72 | |
FSI | 5-(ACETYLAMINO)-2,6-ANHYDRO-3,5- DIDEOXY-3-FLUORONONONIC ACID | A | 2FHR | 0.72 | |
FSI | 5-(ACETYLAMINO)-2,6-ANHYDRO-3,5- DIDEOXY-3-FLUORONONONIC ACID | A | 2A75 | 0.72 | |
FSI | 5-(ACETYLAMINO)-2,6-ANHYDRO-3,5- DIDEOXY-3-FLUORONONONIC ACID | A,B | 2VK7 | 0.72 | |
7GP | ETHYL-N-(BETA-D-GLUCOPYRANOSYL)OXAMATE | A | 2F3S | 0.72 | |
AHE | 2-AMINO-4-[1-CARBOXYMETHYL-CARBAMOYL)- 2-HYDROXYMETHYLSULFANYL-ETHYLCARBAMOYL]- BUTYRIC ACID | A | 3BHM | 0.71 | |
AHE | 2-AMINO-4-[1-CARBOXYMETHYL-CARBAMOYL)- 2-HYDROXYMETHYLSULFANYL-ETHYLCARBAMOYL]- BUTYRIC ACID | A,B | 1MC5 | 0.71 | |
MNA | 2-O-METHYL-5-N-ACETYL-ALPHA-D- NEURAMINIC ACID | A | 2P3I | 0.7 | |
MNA | 2-O-METHYL-5-N-ACETYL-ALPHA-D- NEURAMINIC ACID | A | 1KQR | 0.7 | |
MNA | 2-O-METHYL-5-N-ACETYL-ALPHA-D- NEURAMINIC ACID | A,B,C,D,E,F | 1HGH | 0.7 | |
MNA | 2-O-METHYL-5-N-ACETYL-ALPHA-D- NEURAMINIC ACID | A,B | 2I2S | 0.7 | |
MNA | 2-O-METHYL-5-N-ACETYL-ALPHA-D- NEURAMINIC ACID | A | 2P3J | 0.7 | |
MNA | 2-O-METHYL-5-N-ACETYL-ALPHA-D- NEURAMINIC ACID | A,B,C,D,E,F | 1HGE | 0.7 | |
MNA | 2-O-METHYL-5-N-ACETYL-ALPHA-D- NEURAMINIC ACID | A | 2P3K | 0.7 | |
NAY | 6,7,8,9-TETRAHYDROXY-5-METHYLCARBOXAMIDO- 2-OXONONANOIC ACID | A,C | 1F74 | 0.76 | |
6GP | METHYL-N-(BETA-D-GLUCOPYRANOSYL)OXAMATE | A | 2F3Q | 0.71 | |
NGC | 3,5-dideoxy-5-[(hydroxyacetyl)amino]- D-glycero-alpha-D-galacto-non-2- ulopyranosonic acid | A,B,C,D,E | 3DWP | 0.71 | |
NGC | 3,5-dideoxy-5-[(hydroxyacetyl)amino]- D-glycero-alpha-D-galacto-non-2- ulopyranosonic acid | A,B,C,D,E | 3DWQ | 0.71 | |
NAV | 6,7,8,9-TETRAHYDROXY-5-METHYLCARBOXAMIDO- 4-OXONONANOIC ACID | A,C | 1F7B | 0.79 | |
HMN | 2,4,6,7,8,9-HEXAHYDROXY-5-METHYLCARBOXAMIDO NONANOIC ACID | A,B,C,D | 1F73 | 0.78 | |
233 | [5-(3,4,5-TRIHYDROXY-6-HYDROXYMETHYL- TETRAHYDRO-PYRAN-2-YLCARBAMOYL)- PENTYL]-CARBAMIC ACID METHYL ESTER | D,E,F,G,H | 1MD2 | 0.71 | |
C6L | N-hexanoyl-L-homoserine | A | 3DHA | 0.7 | |
C6L | N-hexanoyl-L-homoserine | A | 3DHB | 0.7 | |
LAS | N-acetyl-S-({(2R,3S,4R)-3-hydroxy- 2-[(1S)-1-hydroxy-2-methylpropyl]- 4-methyl-5-oxopyrrolidin-2-yl}carbonyl)cysteine | A,B | 3DPM | 0.73 | |
4GP | N-(BETA-D-GLUCOPYRANOSYL)OXAMIC ACID | A | 2F3P | 0.71 | |
ANA | 4-O-ACETYL-ALPHA-2-OMETHYL-5-N- ACETYL-ALPHA-D-NEURAMINIC ACID | A,B,C,D,E,F | 1HGI | 0.7 | |
AMU | BETA-N-ACETYLMURAMIC ACID | A,B,C,D | 2APH | 0.71 | |
AMU | BETA-N-ACETYLMURAMIC ACID | A,P | 1TWQ | 0.71 | |
AMU | BETA-N-ACETYLMURAMIC ACID | A | 1D0K | 0.71 | |
AMU | BETA-N-ACETYLMURAMIC ACID | S | 9LYZ | 0.71 | |
AMU | BETA-N-ACETYLMURAMIC ACID | E,S | 148L | 0.71 | |
AMU | BETA-N-ACETYLMURAMIC ACID | D,K | 3CYQ | 0.71 | |
AMU | BETA-N-ACETYLMURAMIC ACID | U | 2AIZ | 0.71 | |
NAU | 4,4,6,7,8,9-HEXAHYDROXY-5-METHYLCARBOXAMIDONONANOIC ACID | A,C | 1F7B | 0.76 | |
MDZ | N~6~-METHYL-6-OXO-L-LYSINE - 2- [(3-MERCAPTOBUTANOYL)OXY]-3-METHYLBUTANOIC ACID | A | 1W3V | 0.71 | |
MUB | N-ACETYLMURAMIC ACID | L,N | 1WCO | 0.71 |